Clin2
NCT07434791Likely a fitRecruiting

Goal-directed therapy to protect kidneys and heart in diabetic kidney disease

Diabetic Kidney Disease (DKD)Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease

Treatments studied

Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.

This study tests whether a goal-directed treatment plan using several medications can lower the risk of kidney and heart problems for people with diabetes and kidney disease. It aims to help you manage your condition more effectively.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years old or older.
  • You must have type 2 diabetes.
  • You must have kidney disease, shown by a reduced kidney function test (eGFR between 25 and 60) or by having protein in your urine (UACR score of 30 or higher).
  • You must have a high risk for heart problems, for example, a past heart attack, stroke, or narrowed leg arteries, or you are 40 or older with high cholesterol, high blood pressure, or an irregular heartbeat (atrial fibrillation).
  • You must be willing to start new medications for your kidneys or heart.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07811427Not yet recruiting· Phase 4
Coordinated care for heart, kidney, and diabetes health

This study tests whether a team of doctors and nurses working together can improve heart and kidney health in people with type 2 diabetes and chronic kidney disease. The team will coordinate care for blood sugar, blood pressure, and kidney function.

NCT06906640Recruiting
Improving Kidney Care for People with Type 2 Diabetes

This study tests a program to help primary care doctors better screen and manage kidney problems in people with type 2 diabetes. It aims to see if using recommended medicines can slow kidney disease and improve health.

Birmingham, Alabama
NCT07605390Enrolling by invitation
Prescription help for heart, kidney, and diabetes care

This study tests whether a computer program can help doctors choose the best medicines for people with type 2 diabetes who also have kidney or heart problems. The goal is to improve overall health by making sure patients receive treatments that are proven to help.

Dallas, Texas
NCT07169422Recruiting
Pharmacist prescribing for kidney care in type 2 diabetes

This study tests whether having a pharmacist prescribe kidney-protective medications works better than usual care for people with type 2 diabetes and early kidney disease. If you don't have a family doctor, you may be able to get these medications more easily through a pharmacist.

Halifax, Nova Scotia
NCT07547878Enrolling by invitation· Phase 4
Starting four kidney-protective medicines together for type 2 diabetes

This study looks at whether starting four recommended medications all at once—instead of one by one—is safe and better for protecting the kidneys in people with type 2 diabetes and early kidney damage. You would receive all four medicines together and be closely monitored by the study team.

Temple, Texas
NCT06654921Not yet recruiting
Remote ischemic conditioning for diabetic kidney disease

This trial tests a treatment called remote ischemic conditioning, which uses brief blood pressure cuff inflations on your arm or leg to help protect your kidneys. It might slow down kidney damage in people with diabetes and kidney disease.

Hear when a new Chronic kidney disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.